Download PDF
Thromb Haemost 1992; 67(05): 585-586
DOI: 10.1055/s-0038-1648499
Letters to the Editor
Schattauer GmbH Stuttgart

Histidine-Rich Glycoprotein (HRG) in Uncomplicated Pregnancy and Mild and Moderate Preeclampsia

W M Halbmayer
Central Laboratory, Municipal Hospital of the City of Vienna-Lainz, A-1130 Vienna, Austria
,
P Hopmeier
*   Central Laboratory, Municipal Hospital Rudolfstiftung, Vienna
,
C Feichtinger
Central Laboratory, Municipal Hospital of the City of Vienna-Lainz, A-1130 Vienna, Austria
,
K Rubi
**   Central Laboratory, Kaiserin-Elisabeth Hospital, Vienna
,
M Fischer
Central Laboratory, Municipal Hospital of the City of Vienna-Lainz, A-1130 Vienna, Austria
› Author Affiliations
Further Information

Publication History

Received 13 May 1991

Accepted after revision 04 November 1991

Publication Date:
03 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Stirling Y, Woolf L, North WRS, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemostas 1984; 52: 176-182
    PubMedGoogle Scholar
  • 2 Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest 1981; 12: 141-154
    CrossrefPubMedGoogle Scholar
  • 3 Kruithof EKO, Tran-Thang C, Gudinchet A, Hauert J, Nicoloso G, Genton C, Welti H, Bachmann F. Fibrinolysis in pregnancy: A study of plasminogen activator inhibitors. Blood 1987; 69: 460-466
    PubMedGoogle Scholar
  • 4 Walker JE, Campbell DM, Ogston D. Blood levels of proteinase inhibitors in pregnancy. Br J Obstet Gynaecol 1982; 89: 208-210
    CrossrefPubMedGoogle Scholar
  • 5 Morgan WT, Koskelo P, Koenig H, Conway TP. Human histidine-rich glycoprotein. II. Serum levels in adults, pregnant women and neonates. Proc Soc Exp Biol Med 1978; 158: 647-651
    CrossrefPubMedGoogle Scholar
  • 6 Haukkamaa M, Morgan WT, Koskelo P. Serum histidine-rich glycoprotein during pregnancy and hormone treatment. Scand J Clin Lab Invest 1983; 43: 591-595
    CrossrefPubMedGoogle Scholar
  • 7 Heimburger N, Haupt H, Kranz T, Baudner S. Humanserumproteine mit hoher Affinitat zu Carboxymethylzellulose, II. Physikalisch-chemische und immunologische Charakterisierung eines histidin-reichen 3,8S-alpha2-Glykoproteins (CM-Protein I). Hoppe-Seyler’s Z Physiol Chem 1972; 353: 1133-1140
    PubMedGoogle Scholar
  • 8 Lijnen HR, Hoylaerts M, Collen D. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein. J Biol Chem 1980; 255: 10214-10222
    PubMedGoogle Scholar
  • 9 Peterson CB, Morgan WT, Blackburn MN. Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. J Biol Chem 1987; 262: 7567-7574
    PubMedGoogle Scholar
  • 10 Leung LLK. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J Clin Invest 1986; 77: 1305-1311
    CrossrefPubMedGoogle Scholar
  • 11 Leung LLK, Nachman RL, Harpel PC. Complex formation of platelet thrombospondin with histidine-rich glycoprotein. J Clin Invest 1984; 73: 5-12
    CrossrefPubMedGoogle Scholar
  • 12 Heimburger N. Personal communication 1990
    PubMed
  • 13 Halbmayer WM, Hopmeier P, Mannhalter C, Heuss F, Leodolter S, Rubi K, Fischer M. Cl-esterase inhibitor in uncomplicated pregnancy and mild and moderate preeclampsia. Thromb Haemostas 1991; 65: 134-138
    PubMedGoogle Scholar
  • 14 Goecke C, Schwabe G. Vorschlag einer Stadieneinteilung der Ge-stose. Zentralbl Gynaekol 1965; 42: 1439
    PubMedGoogle Scholar
  • 15 Kemeter P, Friedrich F. Die Endokrinologie der Schwangerschaft. In: Klinik der Frauenheilkunde und Geburtshilfe. Vol.I. Doderlein G, Wulf KH. (eds) Urban and Schwarzenberg; Munich: 1977. Addendum 1978. pp 219-60/31
    Google Scholar
  • 16 Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist 1979; 6: 65-70
    PubMedGoogle Scholar
  • 17 Jespersen J, Kluft C. Decreased levels of histidine-rich glycoprotein (HRG) and increased levels of free plasminogen in women on oral contraceptives low in estrogen. Thromb Haemostas 1982; 48: 283-285
    PubMedGoogle Scholar
  • 18 Gordon EM, Ratnoff OD, Saito H, Donaldson VH, Pensky J, Jones PK. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased Cl esterase inhibitor titers in women taking oral contraceptives. J Lab Clin Med 1980; 96: 762-769
    PubMedGoogle Scholar
  • 19 Jespersen J, Kluft C. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen - levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and Cl-inactivator. Thromb Haemostas 1985; 54: 454-459
    PubMedGoogle Scholar
  • 20 Lijnen HR, Jacobs G, Collen D. Histidine-rich glycoprotein in a normal and a clinical population. Thromb Res 1981; 22: 519-523
    CrossrefPubMedGoogle Scholar
  • 21 Gordon EM, Ratnoff OD, Saito H, Donaldson VH, Pensky J, Jones PK. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased Cl esterase inhibitor titers in women taking oral contraceptives. J Lab Clin Med 1980; 96: 762-769
    PubMedGoogle Scholar
  • 22 Halbmayer WM. Unpublished data 1991
    PubMed
  • 23 Lappin D, Whaley K. Regulation of Cl-inhibitor synthesis by interferons and other agents. Behring Inst Mitt 1989; 84: 180-192
    PubMedGoogle Scholar